Abstract Immune checkpoint blockers (ICBs) have been applied for cancer therapy and achieved great success in the field of cancer immunotherapy. Nevertheless. the broad application of ICBs is limited by the low response rate. To address this issue. https://foldlyers.shop/product-category/sockets/